Compass Therapeutics (CMPX) Current Leases (2021 - 2026)
Compass Therapeutics recorded quarterly Current Leases of $1.4 million in Q1 2026, up 37.3% quarter-over-quarter from $1.0 million in Q4 2025, and up 1159.63% year-over-year from $109000.0 in Q1 2025.
Compass Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Current Leases rose 1159.63% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 1159.63% YoY), while the FY2025 annual figure was $1.0 million, up 195.86% from the prior year.
- Current Leases came in at $1.4 million for Q1 2026 at Compass Therapeutics, up from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.4 million in Q1 2026 to a low of $109000.0 in Q1 2025.
- A 5-year average of $932352.9 and a median of $1.1 million in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases slumped 91.09% in 2025 and jumped 1159.63% in 2026, its largest moves.
- Compass Therapeutics' Current Leases stood at $1.1 million in 2022, then rose by 9.12% to $1.2 million in 2023, then tumbled by 71.76% to $338000.0 in 2024, then soared by 195.86% to $1.0 million in 2025, then jumped by 37.3% to $1.4 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.4 million, $1.0 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 271,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 338,000.00 |
| Sep 30, 2024 | 557,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 989,000.00 |
| Sep 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.03 Mn |